Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
Novo Nordisk’s stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors hoping for…
1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now
Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily…
